Amerigroup Executives Under Fire, Selling Shares By The Hundreds Of Thousands

 

AMERIGROUP Corporation (NYSE:AGP) and its board of directors are currently under investigation by Glancy Binkow & Goldberg LLP, which is looking into the relation between the directors and the proposed acquisition of the company by WellPoint Inc, valued at $4.9 billion.

The allegations come as company officials unload hundreds of thousands of dollars in company stock, indicating they may not be too confident about the formal investigation.

The investigation will take place to help decide whether the Amerigroup board of directors breached their fiduciary duties to stockholders by not appropriately shopping the company before entering into the proposed transaction. Investigators are also looking to see if the company divulged all necessary information to its shareholders, including information on the company's recent substantial growth, and one analysts' set target price of $95.00.

However, James Truess, executive vice president and CFO, sold 5,100 shares that ranged between $60.86 and $65.30 for a total of $317,050 last month. Total insider transactions from the company amounted to $881,020 in the last three months, according to insider trading reports. 

Read Full Insider Report For:   AGP  |

Related News:

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.